Walter G, Werchau H
J Cell Biochem. 1982;19(2):119-25. doi: 10.1002/jcb.240190203.
Antiserum against the synthetic peptide Lys-Arg-Ser-Arg-His-Phe, corresponding to the carboxy terminus of polyoma virus medium tumor antigen (medium T antigen), immunoprecipitates a protein of 36,000 daltons from polyoma virus-infected and uninfected cell extracts treated with the sulfhydryl group reagent N-ethyl-maleimide. This protein appears to share an antigenic determinant with medium T antigen that is normally buried inside the protein or covered up by another protein or cellular structure. The two-dimensional tryptic fingerprints of the 36K protein and of medium T antigen are apparently unrelated to each other. Antiserum against the octapeptide Ac-Met-Asp-Lys-Val-Leu-Asn-Arg-Tyr, including the amino-terminal heptapeptide sequence of the simian virus 40 (SV40) large tumor (T) and small T antigens, cross-reacts with polyoma virus large T antigen, which has an identical amino-terminal heptapeptide sequence except that Lys is replaced by Arg and Asn by Ser. The problem of cross-reactivities of antipeptide sera is discussed.
针对与多瘤病毒中肿瘤抗原(中T抗原)羧基末端相对应的合成肽Lys-Arg-Ser-Arg-His-Phe的抗血清,可从用巯基试剂N-乙基马来酰亚胺处理过的多瘤病毒感染和未感染细胞提取物中免疫沉淀出一种36,000道尔顿的蛋白质。这种蛋白质似乎与中T抗原共享一个抗原决定簇,该抗原决定簇通常埋藏在蛋白质内部或被另一种蛋白质或细胞结构掩盖。36K蛋白质和中T抗原的二维胰蛋白酶指纹图谱显然彼此无关。针对八肽Ac-Met-Asp-Lys-Val-Leu-Asn-Arg-Tyr(包括猴病毒40(SV40)大肿瘤(T)和小T抗原的氨基末端七肽序列)的抗血清与多瘤病毒大T抗原发生交叉反应,除了Lys被Arg取代且Asn被Ser取代外,其氨基末端七肽序列相同。本文讨论了抗肽血清交叉反应性的问题。